Steven Mings, MD
Dermatology · Boise, IDNPI 1548214265
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $75,150 of the $82,046 with a category attached, or 91.6%. 22 manufacturers reported payments, led by Lilly USA, LLC at 49.7% of the total. 2025 is the largest year on record at $38,623, more than ten times the $784 reported in 2019. Among dermatology clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $429.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$41K
- Galderma Laboratories, L.p.$39K
- AbbVie$665
- Janssen Scientific Affairs, LLC$295
- Sun Pharmaceutical Industries Inc.$268
- LEO Pharma Inc.$253
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$75,15092%
- Travel & lodging$2,7813%
- Food & beverage$3,9495%
- Education$1670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 53 | $40,774 |
| Galderma Laboratories, L.p. | 31 | $38,597 |
| AbbVie | 35 | $665 |
| Janssen Scientific Affairs, LLC | 6 | $295 |
| Sun Pharmaceutical Industries Inc. | 12 | $268 |
| LEO Pharma Inc. | 8 | $253 |
| Novartis | 10 | $252 |
| UCB, Inc. | 4 | $185 |
| Johnson & Johnson | 4 | $135 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $106 |
| Amgen | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| Sanofi | 3 | $72 |
| Sensus Healthcare, Inc. | 1 | $62 |
| Incyte Corporation | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Strata Skin Sciences, Inc. | 3 | $37 |
| Pfizer | 2 | $29 |
| Krystal Biotech Inc | 1 | $26 |
| Genentech USA, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$82,046 in reported general payments places this provider in the 95th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $120,482 |
| Clobetasol Propionate | 19 | $1,398 |
| Fluorouracil | 11 | $1,013 |
| Minoxidil | 28 | $327 |
| Triamcinolone Acetonide | 24 | $242 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boise
- Dustin PortelaBoise$164K
- Nicholas BlickenstaffBoise$6K
- Jared ScottBoise$3K
- Heather LayherBoise$2K
- Marnie RirieBoise$208
- Lindie BortonBoise$97
- Jennifer DeblieckBoise$0
- Leon NowierskiBoise$0
- Alan OlmsteadTwin Falls$405K
- Ryan HarrisMeridian$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.